 | • レポートコード：D005-08452 • 出版社/出版日：GlobalInfoResearch / 2020年5月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、免疫腫瘍薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。免疫腫瘍薬の種類別市場規模（免疫チェックポイント阻害剤、モノクローナル抗体、サイトカイン免疫療法、癌ワクチン、CAR-T細胞療法）、用途別市場規模（病院、薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Amgen, Inc、Johnson & Johnson、Celgene Corporation、AstraZeneca, Plc、Hoffmann-La Roche AG、Bristol-Myers Squibb、AbbVie, Inc.、Merck & Co.、Eli Lilly and Company、Novartis International AG、Prometheus Therapeutics & Diagnostics、Bavarian Nordic、Pfizer Inc.、ImmunoCellular Therapeutics、Aduro BioTech、Gilead Sciences Inc.、Sanofi S.A.、Celldex Therapeutics、Galena Biopharma、EMD Serono, Inc.、Incyte ・地域別グローバル市場分析 2015年-2020年 ・免疫腫瘍薬の北米市場（アメリカ、カナダ、メキシコ） ・免疫腫瘍薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・免疫腫瘍薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・免疫腫瘍薬の南米市場（ブラジル、アルゼンチン） ・免疫腫瘍薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：免疫チェックポイント阻害剤、モノクローナル抗体、サイトカイン免疫療法、癌ワクチン、CAR-T細胞療法 ・用途別分析：病院、薬局、オンライン薬局 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Immuno-oncology Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.1% in the forecast period of 2020 to 2025 and will expected to reach USD 73080 million by 2025, from USD 53550 million in 2019.
The Immuno-oncology Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Immuno-oncology Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Immuno-oncology Drugs market has been segmented into
Immune Checkpoint Inhibitors
Monoclonal Antibodies
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
By Application, Immuno-oncology Drugs has been segmented into:
Hospitals
Pharmacies
Online Pharmacies
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Immuno-oncology Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Immuno-oncology Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Immuno-oncology Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Immuno-oncology Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Immuno-oncology Drugs Market Share Analysis
Immuno-oncology Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Immuno-oncology Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Immuno-oncology Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Immuno-oncology Drugs are:
Amgen, Inc
Johnson & Johnson
Celgene Corporation
AstraZeneca, Plc
Hoffmann-La Roche AG
Bristol-Myers Squibb
AbbVie, Inc.
Merck & Co.
Eli Lilly and Company
Novartis International AG
Prometheus Therapeutics & Diagnostics
Bavarian Nordic
Pfizer Inc.
ImmunoCellular Therapeutics
Aduro BioTech
Gilead Sciences Inc.
Sanofi S.A.
Celldex Therapeutics
Galena Biopharma
EMD Serono, Inc.
Incyte
Among other players domestic and global, Immuno-oncology Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Immuno-oncology Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Immuno-oncology Drugs, with price, sales, revenue and global market share of Immuno-oncology Drugs in 2018 and 2019.
Chapter 3, the Immuno-oncology Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Immuno-oncology Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Immuno-oncology Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Immuno-oncology Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Immuno-oncology Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Immuno-oncology Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Immune Checkpoint Inhibitors
1.2.3 Monoclonal Antibodies
1.2.4 Cytokine-Based Immunotherapy
1.2.5 Cancer Vaccines
1.2.6 CAR-T Cell Therapy
1.3 Market Analysis by Application
1.3.1 Overview: Global Immuno-oncology Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Pharmacies
1.3.4 Online Pharmacies
1.4 Overview of Global Immuno-oncology Drugs Market
1.4.1 Global Immuno-oncology Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Amgen, Inc
2.1.1 Amgen, Inc Details
2.1.2 Amgen, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Amgen, Inc SWOT Analysis
2.1.4 Amgen, Inc Product and Services
2.1.5 Amgen, Inc Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Johnson & Johnson SWOT Analysis
2.2.4 Johnson & Johnson Product and Services
2.2.5 Johnson & Johnson Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Celgene Corporation
2.3.1 Celgene Corporation Details
2.3.2 Celgene Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Celgene Corporation SWOT Analysis
2.3.4 Celgene Corporation Product and Services
2.3.5 Celgene Corporation Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 AstraZeneca, Plc
2.4.1 AstraZeneca, Plc Details
2.4.2 AstraZeneca, Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 AstraZeneca, Plc SWOT Analysis
2.4.4 AstraZeneca, Plc Product and Services
2.4.5 AstraZeneca, Plc Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Hoffmann-La Roche AG
2.5.1 Hoffmann-La Roche AG Details
2.5.2 Hoffmann-La Roche AG Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Hoffmann-La Roche AG SWOT Analysis
2.5.4 Hoffmann-La Roche AG Product and Services
2.5.5 Hoffmann-La Roche AG Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bristol-Myers Squibb
2.6.1 Bristol-Myers Squibb Details
2.6.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bristol-Myers Squibb SWOT Analysis
2.6.4 Bristol-Myers Squibb Product and Services
2.6.5 Bristol-Myers Squibb Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 AbbVie, Inc.
2.7.1 AbbVie, Inc. Details
2.7.2 AbbVie, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 AbbVie, Inc. SWOT Analysis
2.7.4 AbbVie, Inc. Product and Services
2.7.5 AbbVie, Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Merck & Co.
2.8.1 Merck & Co. Details
2.8.2 Merck & Co. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Merck & Co. SWOT Analysis
2.8.4 Merck & Co. Product and Services
2.8.5 Merck & Co. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Eli Lilly and Company
2.9.1 Eli Lilly and Company Details
2.9.2 Eli Lilly and Company Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Eli Lilly and Company SWOT Analysis
2.9.4 Eli Lilly and Company Product and Services
2.9.5 Eli Lilly and Company Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Novartis International AG
2.10.1 Novartis International AG Details
2.10.2 Novartis International AG Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Novartis International AG SWOT Analysis
2.10.4 Novartis International AG Product and Services
2.10.5 Novartis International AG Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Prometheus Therapeutics & Diagnostics
2.11.1 Prometheus Therapeutics & Diagnostics Details
2.11.2 Prometheus Therapeutics & Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Prometheus Therapeutics & Diagnostics SWOT Analysis
2.11.4 Prometheus Therapeutics & Diagnostics Product and Services
2.11.5 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Bavarian Nordic
2.12.1 Bavarian Nordic Details
2.12.2 Bavarian Nordic Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Bavarian Nordic SWOT Analysis
2.12.4 Bavarian Nordic Product and Services
2.12.5 Bavarian Nordic Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Pfizer Inc.
2.13.1 Pfizer Inc. Details
2.13.2 Pfizer Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Pfizer Inc. SWOT Analysis
2.13.4 Pfizer Inc. Product and Services
2.13.5 Pfizer Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 ImmunoCellular Therapeutics
2.14.1 ImmunoCellular Therapeutics Details
2.14.2 ImmunoCellular Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 ImmunoCellular Therapeutics SWOT Analysis
2.14.4 ImmunoCellular Therapeutics Product and Services
2.14.5 ImmunoCellular Therapeutics Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Aduro BioTech
2.15.1 Aduro BioTech Details
2.15.2 Aduro BioTech Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Aduro BioTech SWOT Analysis
2.15.4 Aduro BioTech Product and Services
2.15.5 Aduro BioTech Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Gilead Sciences Inc.
2.16.1 Gilead Sciences Inc. Details
2.16.2 Gilead Sciences Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Gilead Sciences Inc. SWOT Analysis
2.16.4 Gilead Sciences Inc. Product and Services
2.16.5 Gilead Sciences Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Sanofi S.A.
2.17.1 Sanofi S.A. Details
2.17.2 Sanofi S.A. Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Sanofi S.A. SWOT Analysis
2.17.4 Sanofi S.A. Product and Services
2.17.5 Sanofi S.A. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Celldex Therapeutics
2.18.1 Celldex Therapeutics Details
2.18.2 Celldex Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Celldex Therapeutics SWOT Analysis
2.18.4 Celldex Therapeutics Product and Services
2.18.5 Celldex Therapeutics Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 Galena Biopharma
2.19.1 Galena Biopharma Details
2.19.2 Galena Biopharma Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Galena Biopharma SWOT Analysis
2.19.4 Galena Biopharma Product and Services
2.19.5 Galena Biopharma Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.20 EMD Serono, Inc.
2.20.1 EMD Serono, Inc. Details
2.20.2 EMD Serono, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 EMD Serono, Inc. SWOT Analysis
2.20.4 EMD Serono, Inc. Product and Services
2.20.5 EMD Serono, Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.21 Incyte
2.21.1 Incyte Details
2.21.2 Incyte Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 Incyte SWOT Analysis
2.21.4 Incyte Product and Services
2.21.5 Incyte Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Immuno-oncology Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Immuno-oncology Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Immuno-oncology Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Immuno-oncology Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Immuno-oncology Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Immuno-oncology Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Immuno-oncology Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Immuno-oncology Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Immuno-oncology Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Immuno-oncology Drugs Sales and Growth Rate (2015-2020)
4.5 South America Immuno-oncology Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Immuno-oncology Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Immuno-oncology Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Immuno-oncology Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Immuno-oncology Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Immuno-oncology Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Immuno-oncology Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Immuno-oncology Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Immuno-oncology Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Immuno-oncology Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Immuno-oncology Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Immuno-oncology Drugs Sales and Growth Rate (2015-2020)
6.3 UK Immuno-oncology Drugs Sales and Growth Rate (2015-2020)
6.4 France Immuno-oncology Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Immuno-oncology Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Immuno-oncology Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Immuno-oncology Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Immuno-oncology Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Immuno-oncology Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Immuno-oncology Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Immuno-oncology Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Immuno-oncology Drugs Sales and Growth Rate (2015-2020)
7.5 India Immuno-oncology Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Immuno-oncology Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Immuno-oncology Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Immuno-oncology Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Immuno-oncology Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Immuno-oncology Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Immuno-oncology Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Immuno-oncology Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Immuno-oncology Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Immuno-oncology Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Immuno-oncology Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Immuno-oncology Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Immuno-oncology Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Immuno-oncology Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Immuno-oncology Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Immuno-oncology Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Immuno-oncology Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Immuno-oncology Drugs Price by Type (2015-2020)
11 Global Immuno-oncology Drugs Market Segment by Application
11.1 Global Immuno-oncology Drugs Sales Market Share by Application (2015-2020)
11.2 Global Immuno-oncology Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Immuno-oncology Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Immuno-oncology Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Immuno-oncology Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Immuno-oncology Drugs Market Forecast (2021-2025)
12.2.2 Europe Immuno-oncology Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Immuno-oncology Drugs Market Forecast (2021-2025)
12.2.4 South America Immuno-oncology Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Immuno-oncology Drugs Market Forecast (2021-2025)
12.3 Immuno-oncology Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Immuno-oncology Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Immuno-oncology Drugs Market Share Forecast by Type (2021-2025)
12.4 Immuno-oncology Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Immuno-oncology Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Immuno-oncology Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Immuno-oncology Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Immuno-oncology Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Immuno-oncology Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Amgen, Inc Basic Information, Manufacturing Base and Competitors
Table 8. Amgen, Inc Immuno-oncology Drugs Major Business
Table 9. Amgen, Inc Immuno-oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 10. Amgen, Inc SWOT Analysis
Table 11. Amgen, Inc Immuno-oncology Drugs Product and Services
Table 12. Amgen, Inc Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 14. Johnson & Johnson Immuno-oncology Drugs Major Business
Table 15. Johnson & Johnson Immuno-oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Johnson & Johnson SWOT Analysis
Table 17. Johnson & Johnson Immuno-oncology Drugs Product and Services
Table 18. Johnson & Johnson Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table 20. Celgene Corporation Immuno-oncology Drugs Major Business
Table 21. Celgene Corporation Immuno-oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Celgene Corporation SWOT Analysis
Table 23. Celgene Corporation Immuno-oncology Drugs Product and Services
Table 24. Celgene Corporation Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. AstraZeneca, Plc Basic Information, Manufacturing Base and Competitors
Table 26. AstraZeneca, Plc Immuno-oncology Drugs Major Business
Table 27. AstraZeneca, Plc Immuno-oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 28. AstraZeneca, Plc SWOT Analysis
Table 29. AstraZeneca, Plc Immuno-oncology Drugs Product and Services
Table 30. AstraZeneca, Plc Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Hoffmann-La Roche AG Basic Information, Manufacturing Base and Competitors
Table 32. Hoffmann-La Roche AG Immuno-oncology Drugs Major Business
Table 33. Hoffmann-La Roche AG Immuno-oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Hoffmann-La Roche AG SWOT Analysis
Table 35. Hoffmann-La Roche AG Immuno-oncology Drugs Product and Services
Table 36. Hoffmann-La Roche AG Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 38. Bristol-Myers Squibb Immuno-oncology Drugs Major Business
Table 39. Bristol-Myers Squibb Immuno-oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 40. Bristol-Myers Squibb SWOT Analysis
Table 41. Bristol-Myers Squibb Immuno-oncology Drugs Product and Services
Table 42. Bristol-Myers Squibb Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. AbbVie, Inc. Basic Information, Manufacturing Base and Competitors
Table 44. AbbVie, Inc. Immuno-oncology Drugs Major Business
Table 45. AbbVie, Inc. Immuno-oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 46. AbbVie, Inc. SWOT Analysis
Table 47. AbbVie, Inc. Immuno-oncology Drugs Product and Services
Table 48. AbbVie, Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 50. Merck & Co. Immuno-oncology Drugs Major Business
Table 51. Merck & Co. Immuno-oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 52. Merck & Co. SWOT Analysis
Table 53. Merck & Co. Immuno-oncology Drugs Product and Services
Table 54. Merck & Co. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 56. Eli Lilly and Company Immuno-oncology Drugs Major Business
Table 57. Eli Lilly and Company Immuno-oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 58. Eli Lilly and Company SWOT Analysis
Table 59. Eli Lilly and Company Immuno-oncology Drugs Product and Services
Table 60. Eli Lilly and Company Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Novartis International AG Basic Information, Manufacturing Base and Competitors
Table 62. Novartis International AG Immuno-oncology Drugs Major Business
Table 63. Novartis International AG Immuno-oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 64. Novartis International AG SWOT Analysis
Table 65. Novartis International AG Immuno-oncology Drugs Product and Services
Table 66. Novartis International AG Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Prometheus Therapeutics & Diagnostics Basic Information, Manufacturing Base and Competitors
Table 68. Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Major Business
Table 69. Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 70. Prometheus Therapeutics & Diagnostics SWOT Analysis
Table 71. Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Product and Services
Table 72. Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Bavarian Nordic Basic Information, Manufacturing Base and Competitors
Table 74. Bavarian Nordic Immuno-oncology Drugs Major Business
Table 75. Bavarian Nordic Immuno-oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 76. Bavarian Nordic SWOT Analysis
Table 77. Bavarian Nordic Immuno-oncology Drugs Product and Services
Table 78. Bavarian Nordic Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 80. Pfizer Inc. Immuno-oncology Drugs Major Business
Table 81. Pfizer Inc. Immuno-oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 82. Pfizer Inc. SWOT Analysis
Table 83. Pfizer Inc. Immuno-oncology Drugs Product and Services
Table 84. Pfizer Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. ImmunoCellular Therapeutics Basic Information, Manufacturing Base and Competitors
Table 86. ImmunoCellular Therapeutics Immuno-oncology Drugs Major Business
Table 87. ImmunoCellular Therapeutics Immuno-oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 88. ImmunoCellular Therapeutics SWOT Analysis
Table 89. ImmunoCellular Therapeutics Immuno-oncology Drugs Product and Services
Table 90. ImmunoCellular Therapeutics Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Aduro BioTech Basic Information, Manufacturing Base and Competitors
Table 92. Aduro BioTech Immuno-oncology Drugs Major Business
Table 93. Aduro BioTech Immuno-oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 94. Aduro BioTech SWOT Analysis
Table 95. Aduro BioTech Immuno-oncology Drugs Product and Services
Table 96. Aduro BioTech Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Gilead Sciences Inc. Basic Information, Manufacturing Base and Competitors
Table 98. Gilead Sciences Inc. Immuno-oncology Drugs Major Business
Table 99. Gilead Sciences Inc. Immuno-oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 100. Gilead Sciences Inc. SWOT Analysis
Table 101. Gilead Sciences Inc. Immuno-oncology Drugs Product and Services
Table 102. Gilead Sciences Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Sanofi S.A. Basic Information, Manufacturing Base and Competitors
Table 104. Sanofi S.A. Immuno-oncology Drugs Major Business
Table 105. Sanofi S.A. Immuno-oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 106. Sanofi S.A. SWOT Analysis
Table 107. Sanofi S.A. Immuno-oncology Drugs Product and Services
Table 108. Sanofi S.A. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Celldex Therapeutics Immuno-oncology Drugs Type and Application
Table 110. Celldex Therapeutics Immuno-oncology Drugs Major Business
Table 111. Celldex Therapeutics Immuno-oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 112. Celldex Therapeutics SWOT Analysis
Table 113. Celldex Therapeutics Immuno-oncology Drugs Product and Services
Table 114. Celldex Therapeutics Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 115. Galena Biopharma Basic Information, Manufacturing Base and Competitors
Table 116. Galena Biopharma Immuno-oncology Drugs Major Business
Table 117. Galena Biopharma Immuno-oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 118. Galena Biopharma SWOT Analysis
Table 119. Galena Biopharma Immuno-oncology Drugs Product and Services
Table 120. Galena Biopharma Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 121. EMD Serono, Inc. Basic Information, Manufacturing Base and Competitors
Table 122. EMD Serono, Inc. Immuno-oncology Drugs Major Business
Table 123. EMD Serono, Inc. Immuno-oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 124. EMD Serono, Inc. SWOT Analysis
Table 125. EMD Serono, Inc. Immuno-oncology Drugs Product and Services
Table 126. EMD Serono, Inc. Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 127. Incyte Basic Information, Manufacturing Base and Competitors
Table 128. Incyte Immuno-oncology Drugs Major Business
Table 129. Incyte Immuno-oncology Drugs Total Revenue (USD Million) (2017-2018)
Table 130. Incyte SWOT Analysis
Table 131. Incyte Immuno-oncology Drugs Product and Services
Table 132. Incyte Immuno-oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 133. Global Immuno-oncology Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 134. Global Immuno-oncology Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 135. Global Immuno-oncology Drugs Sales by Regions (2015-2020) (K Units)
Table 136. Global Immuno-oncology Drugs Sales Market Share by Regions (2015-2020)
Table 137. Global Immuno-oncology Drugs Revenue by Regions (2015-2020) (USD Million)
Table 138. North America Immuno-oncology Drugs Sales by Countries (2015-2020) (K Units)
Table 139. North America Immuno-oncology Drugs Sales Market Share by Countries (2015-2020)
Table 140. North America Immuno-oncology Drugs Revenue by Countries (2015-2020) (USD Million)
Table 141. North America Immuno-oncology Drugs Revenue Market Share by Countries (2015-2020)
Table 142. Europe Immuno-oncology Drugs Sales by Countries (2015-2020) (K Units)
Table 143. Europe Immuno-oncology Drugs Sales Market Share by Countries (2015-2020)
Table 144. Europe Immuno-oncology Drugs Revenue by Countries (2015-2020) (USD Million)
Table 145. Asia-Pacific Immuno-oncology Drugs Sales by Regions (2015-2020) (K Units)
Table 146. Asia-Pacific Immuno-oncology Drugs Sales Market Share by Regions (2015-2020)
Table 147. Asia-Pacific Immuno-oncology Drugs Revenue by Regions (2015-2020) (USD Million)
Table 148. South America Immuno-oncology Drugs Sales by Countries (2015-2020) (K Units)
Table 149. South America Immuno-oncology Drugs Sales Market Share by Countries (2015-2020)
Table 150. South America Immuno-oncology Drugs Revenue by Countries (2015-2020) (USD Million)
Table 151. South America Immuno-oncology Drugs Revenue Market Share by Countries (2015-2020)
Table 152. Middle East & Africa Immuno-oncology Drugs Sales by Countries (2015-2020) (K Units)
Table 153. Middle East & Africa Immuno-oncology Drugs Sales Market Share by Countries (2015-2020)
Table 154. Middle East & Africa Immuno-oncology Drugs Revenue by Countries (2015-2020) (USD Million)
Table 155. Middle East & Africa Immuno-oncology Drugs Revenue Market Share by Countries (2015-2020)
Table 156. Global Immuno-oncology Drugs Sales by Type (2015-2020) (K Units)
Table 157. Global Immuno-oncology Drugs Sales Share by Type (2015-2020)
Table 158. Global Immuno-oncology Drugs Revenue by Type (2015-2020) (USD Million)
Table 159. Global Immuno-oncology Drugs Revenue Share by Type (2015-2020)
Table 160. Global Immuno-oncology Drugs Sales by Application (2015-2020) (K Units)
Table 161. Global Immuno-oncology Drugs Sales Share by Application (2015-2020)
Table 162. Global Immuno-oncology Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 163. Global Immuno-oncology Drugs Market Share Forecast by Regions (2021-2025)
Table 164. Global Immuno-oncology Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 165. Global Immuno-oncology Drugs Market Share Forecast by Type (2021-2025)
Table 166. Global Immuno-oncology Drugs Sales Forecast by Application (2021-2025)
Table 167. Global Immuno-oncology Drugs Market Share Forecast by Application (2021-2025)
Table 168. Direct Channel Pros & Cons
Table 169. Indirect Channel Pros & Cons
Table 170. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Immuno-oncology Drugs Picture
Figure 2. Global Sales Market Share of Immuno-oncology Drugs by Type in 2019
Figure 3. Immune Checkpoint Inhibitors Picture
Figure 4. Monoclonal Antibodies Picture
Figure 5. Cytokine-Based Immunotherapy Picture
Figure 6. Cancer Vaccines Picture
Figure 7. CAR-T Cell Therapy Picture
Figure 8. Immuno-oncology Drugs Sales Market Share by Application in 2018
Figure 9. Hospitals Picture
Figure 10. Pharmacies Picture
Figure 11. Online Pharmacies Picture
Figure 12. Global Immuno-oncology Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Immuno-oncology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Immuno-oncology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Immuno-oncology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Immuno-oncology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Immuno-oncology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Immuno-oncology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Immuno-oncology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Immuno-oncology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Immuno-oncology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Immuno-oncology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Immuno-oncology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Immuno-oncology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Immuno-oncology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Immuno-oncology Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Immuno-oncology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Immuno-oncology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Immuno-oncology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Immuno-oncology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Immuno-oncology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Immuno-oncology Drugs Sales Market Share by Manufacturer in 2019
Figure 33. Global Immuno-oncology Drugs Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Immuno-oncology Drugs Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Immuno-oncology Drugs Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Immuno-oncology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 38. Global Immuno-oncology Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Immuno-oncology Drugs Revenue Market Share by Regions (2015-2020)
Figure 40. Global Immuno-oncology Drugs Revenue Market Share by Regions in 2018
Figure 41. North America Immuno-oncology Drugs Sales and Growth Rate (2015-2020)
Figure 42. Europe Immuno-oncology Drugs Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Immuno-oncology Drugs Sales and Growth Rate (2015-2020)
Figure 44. South America Immuno-oncology Drugs Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Immuno-oncology Drugs Sales and Growth Rate (2015-2020)
Figure 46. North America Immuno-oncology Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Immuno-oncology Drugs Sales Market Share by Countries (2015-2020)
Figure 48. North America Immuno-oncology Drugs Sales Market Share by Countries in 2018
Figure 49. North America Immuno-oncology Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Immuno-oncology Drugs Revenue Market Share by Countries in 2018
Figure 51. United States Immuno-oncology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Canada Immuno-oncology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Mexico Immuno-oncology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Europe Immuno-oncology Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Immuno-oncology Drugs Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Immuno-oncology Drugs Revenue Market Share by Countries in 2019
Figure 57. Germany Immuno-oncology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 58. UK Immuno-oncology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 59. France Immuno-oncology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Russia Immuno-oncology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Italy Immuno-oncology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Asia-Pacific Immuno-oncology Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Immuno-oncology Drugs Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Immuno-oncology Drugs Revenue Market Share by Regions 2019
Figure 65. China Immuno-oncology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Japan Immuno-oncology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Korea Immuno-oncology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 68. India Immuno-oncology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Southeast Asia Immuno-oncology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 70. South America Immuno-oncology Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Immuno-oncology Drugs Sales Market Share by Countries in 2019
Figure 72. South America Immuno-oncology Drugs Revenue Market Share by Countries in 2019
Figure 73. Brazil Immuno-oncology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Argentina Immuno-oncology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Middle East and Africa Immuno-oncology Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Immuno-oncology Drugs Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Immuno-oncology Drugs Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Immuno-oncology Drugs Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Immuno-oncology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Egypt Immuno-oncology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Turkey Immuno-oncology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 82. South Africa Immuno-oncology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Global Immuno-oncology Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 84. Global Immuno-oncology Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Immuno-oncology Drugs Market Forecast (2021-2025) (K Units)
Figure 86. Europe Sales Immuno-oncology Drugs Market Forecast (2021-2025) (K Units)
Figure 87. Asia-Pacific Sales Immuno-oncology Drugs Market Forecast (2021-2025) (K Units)
Figure 88. South America Sales Immuno-oncology Drugs Market Forecast (2021-2025) (K Units)
Figure 89. Middle East & Africa Sales Immuno-oncology Drugs Market Forecast (2021-2025) (K Units)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
卵巣がん治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Ovarian Cancer Treatment Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ovarian Cancer…- 腎臓がん治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Kidney Cancer Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.1% in the forecast period of 2020 to 2025 and will expected to reach USD 4731.4 million by 2025, from USD 4023.6 million in 2019. The Kidney Cancer Dr…
- CD抗原がん治療の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global CD Antigen Cancer Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The CD Antigen Cancer T…
- ジェネリック腫瘍滅菌注射の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Generic Oncology Sterile Injectable market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.2% in the forecast period of 2020 to 2025 and will expected to reach USD 12600 million by 2025, from USD 9912.3 million in 2019. The G…
- 子宮頸がん治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cervical Cancer Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.2% in the forecast period of 2020 to 2025 and will expected to reach USD 14770 million by 2025, from USD 13550 million in 2019. The Cervical Cancer …